Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.

Treatment of ovarian cancer (OC) remains the biggest challenge among gynecological malignancies. Immune checkpoint blockade therapy is promising in many cancers but shows low response rates in OC b...